Cargando…

Prognostic value of spleen tyrosine kinase in human solid tumors

BACKGROUND: Spleen tyrosine kinase (SYK) was reported to be dysregulated in solid tumors and played an important role in cancer progression. However, the clinical and prognostic values of SYK in solid tumors remain unclear. This meta-analysis investigated the association between SYK expression and c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ni, Beibei, Li, Shi, Liu, Yang, Huang, Yuqian, Li, Zesong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2018
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5996858/ https://www.ncbi.nlm.nih.gov/pubmed/29922076 http://dx.doi.org/10.2147/OTT.S163136

Ejemplares similares

Alternative splicing of spleen tyrosine kinase differentially regulates colorectal cancer progression
por: Ni, Beibei, et al.
Publicado: (2016)

Targeting Spleen Tyrosine Kinase-Bruton's Tyrosine Kinase Axis for Immunologically Mediated Glomerulonephritis
por: Chen, Jin-Shuen, et al.
Publicado: (2014)

AB026. Loss of KCNJ15 expression promotes malignant phenotypes and correlates with poor prognosis in renal carcinoma
por: Liu, Yang, et al.
Publicado: (2018)

Role of spleen tyrosine kinase in liver diseases
por: Kurniawan, Dhadhang Wahyu, et al.
Publicado: (2020)

Spleen tyrosine kinase (SYK) signals are implicated in cardio-cerebrovascular diseases
por: Li, Mohan, et al.
Publicado: (2023)

Tyrosine kinase inhibitors for solid tumors in the past 20 years (2001–2020)
por: Huang, Liling, et al.
Publicado: (2020)

Spleen Tyrosine Kinase Inhibition Modulates p53 Activity
por: Althubiti, Mohammad
Publicado: (2017)

An inhibitor of spleen tyrosine kinase suppresses experimental crescentic glomerulonephritis
por: Han, Yingjie, et al.
Publicado: (2018)

Alzheimer’s disease pathological lesions activate the spleen tyrosine kinase
por: Schweig, Jonas Elias, et al.
Publicado: (2017)

Prognostic Value of Neurotrophic Tyrosine Receptor Kinase Gene Fusions in Solid Tumors for Overall Survival: A Systematic Review and Meta-Analysis
por: Lassen, Ulrik, et al.
Publicado: (2023)

Spleen Tyrosine Kinase Mediates Microglial Activation in Mice With Diabetic Retinopathy
por: Liu, Xiaozhe, et al.
Publicado: (2021)

The spleen tyrosine kinase (SYK): A crucial therapeutic target for diverse liver diseases
por: Zhao, Yaping, et al.
Publicado: (2022)

Loss of KCNJ15 expression promotes malignant phenotypes and correlates with poor prognosis in renal carcinoma
por: Liu, Yang, et al.
Publicado: (2019)

Inhibition of Spleen Tyrosine Kinase Restores Glucocorticoid Sensitivity to Improve Steroid-Resistant Asthma
por: Liu, Qian, et al.
Publicado: (2022)

Prognostic Value of Focal Adhesion Kinase (FAK) in Human Solid Carcinomas: A Meta-Analysis
por: Zeng, Xiao-Qing, et al.
Publicado: (2016)

Spleen tyrosine kinase expression and its correlation with necrosis and high-risk histopathologic features in retinoblastoma
por: Yang, Ya-Li, et al.
Publicado: (2020)

Spleen tyrosine kinase inhibition in the treatment of autoimmune, allergic and autoinflammatory diseases
por: Pamuk, Omer N, et al.
Publicado: (2010)

Spleen tyrosine kinase inhibition restores myeloid homeostasis in COVID-19
por: Wigerblad, Gustaf, et al.
Publicado: (2023)

Immunomodulatory role of spleen tyrosine kinase in chronic inflammatory and autoimmune diseases
por: Zhou, Yaqi, et al.
Publicado: (2023)

Predictive and Prognostic Value of DNA Damage Response Associated Kinases in Solid Tumors
por: Gachechiladze, Mariam, et al.
Publicado: (2020)

Prognostic value and immunological role of FOXM1 in human solid tumors
por: Wei, Guohua, et al.
Publicado: (2022)

Cryptotanshinone inhibits IgE-mediated degranulation through inhibition of spleen tyrosine kinase and tyrosine-protein kinase phosphorylation in mast cells
por: Buyanravjikh, Sumiyasuren, et al.
Publicado: (2021)

Src- and Abl-family kinases activate spleen tyrosine kinase to maximize phagocytosis and Leishmania infection
por: Ullah, Imran, et al.
Publicado: (2023)

A Novel Triazolopyridine-Based Spleen Tyrosine Kinase Inhibitor That Arrests Joint Inflammation
por: Ferguson, Gregory D., et al.
Publicado: (2016)

Phosphorylation impact on Spleen Tyrosine kinase conformation by Surface Enhanced Raman Spectroscopy
por: Cottat, Maximilien, et al.
Publicado: (2017)

The Expression and Clinical Significance of Spleen Tyrosine Kinase in Patients with Coronary Heart Disease
por: Liang, Ke, et al.
Publicado: (2019)

Role of the Spleen Tyrosine Kinase Pathway in Driving Inflammation in IgA Nephropathy
por: McAdoo, Stephen, et al.
Publicado: (2018)

Spleen Tyrosine Kinase Is a Critical Regulator of Neutrophil Responses to Candida Species
por: Negoro, Paige E., et al.
Publicado: (2020)

Spleen Tyrosine Kinase Inhibition Ameliorates Tubular Inflammation in IgA Nephropathy
por: Yiu, Wai Han, et al.
Publicado: (2021)

Spleen Tyrosine Kinase Contributes to Müller Glial Expression of Proangiogenic Cytokines in Diabetes
por: Yerlikaya, Esma I., et al.
Publicado: (2022)

Spleen tyrosine kinase activity regulates epidermal growth factor receptor signaling pathway in ovarian cancer
por: Yu, Yu, et al.
Publicado: (2019)

The Prognostic Value of Tyrosine Kinase SRC Expression in Locally Advanced Rectal Cancer
por: Rühlmann, Felix, et al.
Publicado: (2017)

Pursuing Precision: Receptor Tyrosine Kinase Inhibitors for Treatment of Pediatric Solid Tumors
por: Bellantoni, Andrew J., et al.
Publicado: (2021)

Spleen tyrosine kinase Syk is critical for sustained leukocyte adhesion during inflammation in vivo
por: Frommhold, David, et al.
Publicado: (2007)

Spleen Tyrosine Kinase (Syk) Regulates Systemic Lupus Erythematosus (SLE) T Cell Signaling
por: Grammatikos, Alexandros P., et al.
Publicado: (2013)

Systematic Analysis of Spleen Tyrosine Kinase Expression and its Clinical Outcomes in Various Cancers
por: Alwithenani, Akram I., et al.
Publicado: (2020)

Targeting the splicing isoforms of spleen tyrosine kinase affects the viability of colorectal cancer cells
por: Denis, Vincent, et al.
Publicado: (2022)

Pharmacokinetics and Efficacy of the Spleen Tyrosine Kinase Inhibitor R406 after Ocular Delivery for Retinoblastoma
por: Pritchard, Eleanor M., et al.
Publicado: (2014)

Prognostic value of Flotillin-1 expression in patients with solid tumors
por: Ou, Yang-xi, et al.
Publicado: (2017)

Prognostic value of Onodera’s nutritional index for intermediate- and high-risk gastrointestinal stromal tumors treated with or without tyrosine kinase inhibitors
por: Wang, Feng, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ue5geatjpd4iiqv9fba4loahed